Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in February 2010 on request of the sponsor.
On 3 November 2006, orphan designation (EU/3/06/415) was granted by the European Commission to Dr Manfred Zoltobrocki, Germany, for ciclosporin (implant) for the prevention of rejection of corneal transplant.
The sponsorship was transferred to Lux Biosciences GmbH, Germany, in December 2006.
Prevention of rejection for corneal transplant
|Orphan designation status||
|EU designation number||
|Date of designation||
Documents related to this orphan designation evaluation
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: